Coxsackievirus B3 induction of NFAT: Requirement for myocarditis susceptibility

Virology

Volumn 381, Issue 2, 2008, Pages 155-160

  Huber, S A ^a   Rincon, M ^b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Coxsackievirus; Myocarditis; NFAT; Transcription factor

Indexed keywords

GAMMA INTERFERON; TRANSCRIPTION FACTOR NFAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; COXSACKIE VIRUS B3; DISEASE PREDISPOSITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRUS INDUCTION; VIRUS MYOCARDITIS; VIRUS TITRATION;

ANIMALS; CALCIUM; CD4-POSITIVE T-LYMPHOCYTES; COXSACKIEVIRUS INFECTIONS; DISEASE SUSCEPTIBILITY; ENTEROVIRUS B, HUMAN; GENE EXPRESSION REGULATION; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCARDITIS; MYOCARDIUM; NFATC TRANSCRIPTION FACTORS; PANCREAS; SPLEEN;

ANIMALIA; COXSACKIEVIRUS; MUS; MUS MUSCULUS;

EID: 54549114178     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.08.020     Document Type: Article

References (46)

1. Abreu M.T., and Arditi M. Innate immunity and toll-like receptors: clinical implications of basic science research. J. Pediatr. 144 4 (2004) 421-429
2. Anderson D., Wilson J., Carthy C., Yang D., Kandolf R., and McManus B. Direct interactions of coxsackievirus B3 with immune cells in the splenic compartment of mice susceptible or resistant to myocarditis. J. Virol. 70 (1996) 74632-74645
3. Bowles N., Richardson P., Olsen E., and Archard L. Detection of coxsackie B virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet I (1986) 1120-1122
4. Bowles N.E., Ni J., Kearney D.L., Pauschinger M., Schultheiss H.P., McCarthy R., Hare J., Bricker J.T., Bowles K.R., and Towbin J.A. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 42 3 (2003) 466-472
5. Chow C.W., Rincon M., and Davis R.J. Requirement for transcription factor NFAT in interleukin-2 expression. Mol. Cell. Biol. 19 3 (1999) 2300-2307
6. D'Addario M., Ahmad A., Xu J.W., and Menezes J. Epstein-Barr virus envelope glycoprotein gp350 induces NF-kappaB activation and IL-1beta synthesis in human monocytes-macrophages involving PKC and PI3-K. Faseb J. 13 15 (1999) 2203-2213
7. D'Addario M., Ahmad A., Morgan A., and Menezes J. Binding of the Epstein-Barr virus major envelope glycoprotein gp350 results in the upregulation of the TNF-alpha gene expression in monocytic cells via NF-kappaB involving PKC, PI3-K and tyrosine kinases. J. Mol. Biol. 298 5 (2000) 765-778
8. D'Addario M., Libermann T.A., Xu J., Ahmad A., and Menezes J. Epstein-Barr virus and its glycoprotein-350 upregulate IL-6 in human B-lymphocytes via CD21, involving activation of NF-kappaB and different signaling pathways. J. Mol. Biol. 308 3 (2001) 501-514
9. Esfandiarei M., Boroomand S., Suarez A., Si X., Rahmani M., and McManus B. Coxsackievirus B3 activates nuclear factor kappa B transcription factor via a phosphatidylinositol-3 kinase/protein kinase B-dependent pathway to improve host cell viability. Cell Microbiol. 9 10 (2007) 2358-2371
10. Fairweather D., Kaya Z., Shellam G.R., Lawson C.M., and Rose N.R. From infection to autoimmunity. J. Autoimmun. 16 3 (2001) 175-186
11. Feuer R., Mena I., Pagarigan R.R., Hassett D.E., and Whitton J.L. Coxsackievirus replication and the cell cycle: a potential regulatory mechanism for viral persistence/latency. Med Microbiol Immunol (Berl) (2003)
12. Frolov V.G., Duque H., and Palmenberg A.C. Quantification of endogenous viral polymerase, 3D(pol), in preparations of Mengo and encephalomyocarditis viruses. Virology 260 1 (1999) 148-155
13. Gauntt C., Sakkinen P., Rose N., and Huber S. Picornaviruses: immunopathology and autoimmunity. In: Cunningham M., and Fujinami R. (Eds). Effects of Microbes on the Immune System (2000), Lippincott-Raven Publishers, Philadelphia 313-329
14. Goodfellow I.G., Evans D.J., Blom A.M., Kerrigan D., Miners J.S., Morgan B.P., and Spiller O.B. Inhibition of Coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors. J. Virol. 79 18 (2005) 12016-12024
15. Hasan U., Chaffois C., Gaillard C., Saulnier V., Merck E., Tancredi S., Guiet C., Briere F., Vlach J., Lebecque S., Trinchieri G., and Bates E.E. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J. Immunol. 174 5 (2005) 2942-2950
16. Hogan P.G., Chen L., Nardone J., and Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17 18 (2003) 2205-2232
17. Huber S., Graveline D., Born W., and O'Brien R. Cytokine production by Vgamma+ T cell subsets is an important factor determining CD4+th cell phenotype and susceptibility of BALB/c mice to coxsackievirus B3-induced myocarditis. J. Virol. 75 13 (2001) 5860-5868
18. Huber S., Shi C., and Budd R.C. Gammadelta T cells promote a Th1 response during coxsackievirus B3 infection in vivo: role of Fas and Fas ligand. J. Virol. 76 13 (2002) 6487-6494
19. Huber S., Sartini D., and Exley M. Role of CD1d in coxsackievirus B3-induced myocarditis. J. Immunol. 170 6 (2003) 3147-3153
20. Huber S., Song W.C., and Sartini D. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+T-cell activation in coxsackievirus B3-induced myocarditis. Viral. Immunol. 19 2 (2006) 156-166
21. Im S.H., and Rao A. Activation and deactivation of gene expression by Ca2+/calcineurin-NFAT-mediated signaling. Mol. Cells 18 1 (2004) 1-9
22. Jayanthi S., Deng X., Ladenheim B., McCoy M.T., Cluster A., Cai N.S., and Cadet J.L. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc. Natl. Acad. Sci. U.S.A. 102 3 (2005) 868-873
23. Knowlton K.U., Jeon E.S., Berkley N., Wessely R., and Huber S. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3. J. Virol. 70 11 (1996) 7811-7818
24. Kroczek R.A., Gunter K.C., Germain R.N., and Shevach E.M. Thy-1 functions as a signal transduction molecule in T lymphocytes and transfected B lymphocytes. Nature 322 6075 (1986) 181-184
25. Kwon D., Fuller A.C., Palma J.P., Choi I.H., and Kim B.S. Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-kappa B. Glia 45 3 (2004) 287-296
26. Lauw F.N., Caffrey D.R., and Golenbock D.T. Of mice and man: TLR11 (finally) finds profilin. Trends Immunol. 26 10 (2005) 509-511
27. Liu P., Aitken K., Kong Y.Y., Opavsky M.A., Martino T., Dawood F., Wen W.H., Kozieradzki I., Bachmaier K., Straus D., Mak T.W., and Penninger J.M. The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nat. Med. 6 4 (2000) 429-434
28. Michelsen K.S., Doherty T.M., Shah P.K., and Arditi M. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J. Immunol. 173 10 (2004) 5901-5907
29. Netea M.G., Van der Meer J.W., and Kullberg B.J. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol. 12 11 (2004) 484-488
30. O'Neill L.A. TLRs: Professor Mechnikov, sit on your hat. Trends Immunol. 25 12 (2004) 687-693
31. Pasch A., Kupper J.H., Wolde A., Kandolf R., and Selinka H.C. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. J. Gen. Virol. 80 Pt 12 (1999) 3153-3158
32. Ranger A.M., Oukka M., Rengarajan J., and Glimcher L.H. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Immunity 9 5 (1998) 627-635
33. Rao A., Luo C., and Hogan P.G. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15 (1997) 707-747
34. Rooney J.W., Hodge M.R., McCaffrey P.G., Rao A., and Glimcher L.H. A common factor regulates both Th1-and Th2-specific cytokine gene expression. Embo J. 13 3 (1994) 625-633
35. Rose N.R. The adjuvant effect in infection and autoimmunity. Clin Rev Allergy Immunol (2008)
36. Rueckert R. Picronaviruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Fundamental Virology. 3rd Ed (1996), Lippincott-Raven, Philadelphia, PA.
37. Schreiber E., Matthias P., Muller M., and Shaffner W. Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucleic Acids Res. 17 (1989) 6419
38. Selinka H.C., Wolde A., Sauter M., Kandolf R., and Klingel K. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism. Med. Microbiol. Immunol. 193 2-3 (2004) 127-131
39. Shenoy-Scaria A.M., Kwong J., Fujita T., Olszowy M.W., Shaw A.S., and Lublin D.M. Signal transduction through decay-accelerating factor. Interaction of glycosyl-phosphatidylinositol anchor and protein tyrosine kinases p56lck and p59fyn 1. J. Immunol. 149 11 (1992) 3535-3541
40. Tosello A.C., Mary F., Amiot M., Bernard A., and Mary D. Activation of T cells via CD55: recruitment of early components of the CD3-TCR pathway is required for IL-2 secretion. J. Inflamm. 48 1 (1998) 13-27
41. Triantafilou K., and Triantafilou M. Coxsackievirus B4-induced cytokine production in pancreatic cells is mediated through toll-like receptor 4. J. Virol. 78 20 (2004) 11313-11320
42. Tugores A., Alonso M.A., Sanchez-Madrid F., and de Landazuri M.O. Human T cell activation through the activation-inducer molecule/CD69 enhances the activity of transcription factor AP-1. J. Immunol. 148 7 (1992) 2300-2306
43. Van Houten N., Bouchard P., Moraska A., and Huber S. Selection of an attenuated coxsackievirus B3 variant using a monoclonal antibody reactive to myocyte antigen. J. Virol. 65 (1991) 1286-1290
44. Woodruff J., and Woodruff J. Involvement of T lymphocytes in the pathogenesis of coxsackievirus B3 heart disease. J. Immunol. 113 (1974) 1726-1734
45. Yanagawa B., Spiller O.B., Choy J., Luo H., Cheung P., Zhang H.M., Goodfellow I.G., Evans D.J., Suarez A., Yang D., and McManus B.M. Coxsackievirus B3-associated myocardial pathology and viral load reduced by recombinant soluble human decay-accelerating factor in mice. Lab. Invest. 83 1 (2003) 75-85
46. Yanagawa B., Spiller O.B., Proctor D.G., Choy J., Luo H., Zhang H.M., Suarez A., Yang D., and McManus B.M. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice. J. Infect. Dis. 189 8 (2004) 1431-1439